Angela Djanani

1.2k total citations
34 papers, 797 citations indexed

About

Angela Djanani is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Angela Djanani has authored 34 papers receiving a total of 797 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 11 papers in Molecular Biology and 8 papers in Surgery. Recurrent topics in Angela Djanani's work include Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Sphingolipid Metabolism and Signaling (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Angela Djanani is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (6 papers), Sphingolipid Metabolism and Signaling (5 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Angela Djanani collaborates with scholars based in Austria, Italy and United States. Angela Djanani's co-authors include Christian J. Wiedermann, Nicole C. Kaneider, Daniel H. Sturn, Clemens Feistritzer, Clemens Feistritzer, Josef R. Patsch, Birgit Mosheimer, Kenji Fukudome, Christian Meierhofer and Stefan Dunzendorfer and has published in prestigious journals such as Blood, The Journal of Clinical Endocrinology & Metabolism and The FASEB Journal.

In The Last Decade

Angela Djanani

31 papers receiving 786 citations

Peers

Angela Djanani
Daniel H. Sturn Austria
Wilfried Schgoer Austria
Anne Graham United Kingdom
Véronique Chobaz-Péclat Switzerland
Sung Won Lee South Korea
Ichiro Fuse Japan
David J. Elzi United States
Simon Allen United Kingdom
Yulia Bashenko Israel
Daniel H. Sturn Austria
Angela Djanani
Citations per year, relative to Angela Djanani Angela Djanani (= 1×) peers Daniel H. Sturn

Countries citing papers authored by Angela Djanani

Since Specialization
Citations

This map shows the geographic impact of Angela Djanani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angela Djanani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angela Djanani more than expected).

Fields of papers citing papers by Angela Djanani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angela Djanani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angela Djanani. The network helps show where Angela Djanani may publish in the future.

Co-authorship network of co-authors of Angela Djanani

This figure shows the co-authorship network connecting the top 25 collaborators of Angela Djanani. A scholar is included among the top collaborators of Angela Djanani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angela Djanani. Angela Djanani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santo, Gianpaolo di, et al.. (2025). Peptide receptor radionuclide therapy alone or in combination with temozolomide plus/minus capecitabine in [18F]FDG-positive metastatic neuroendocrine tumors. European Journal of Nuclear Medicine and Molecular Imaging. 53(3). 1927–1938. 1 indexed citations
2.
Santol, Jonas, Birgit Gruenberger, A. Lenauer, et al.. (2024). Perioperative Chemotherapy Including Bevacizumab in Potentially Curable Metastatic Colorectal Cancer: Long-Term Follow-Up of the ASSO-LM1 Trial. Cancers. 16(5). 857–857. 1 indexed citations
3.
Taghizadeh, Hossein, Gerald Webersinke, Stefan Kasper, et al.. (2024). Exploring the impact of durvalumab on biliary tract cancer: insights from real-world clinical data. Cancer Immunology Immunotherapy. 73(12). 251–251. 2 indexed citations
4.
Djanani, Angela. (2024). Innovative therapeutic concepts for biliary tumors. memo - Magazine of European Medical Oncology. 17(1). 20–25.
5.
Djanani, Angela, et al.. (2024). Small cell neuroendocrine prostate cancer with adenocarcinoma components—case report and literature review. Translational Andrology and Urology. 13(5). 868–878. 2 indexed citations
6.
Zoller, Heinz, Maria Effenberger, Georg Oberhuber, et al.. (2023). Liver Transplantation after Successful Downstaging of a Locally Advanced Hepatocellular Carcinoma with Systemic Therapy. Digestive Diseases. 41(4). 641–644. 14 indexed citations
7.
Taghizadeh, Hossein, Angela Djanani, Wolfgang Eisterer, et al.. (2023). Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma – an Austrian expert consensus statement. Frontiers in Oncology. 13. 1225154–1225154. 2 indexed citations
8.
Messner, Franka, Gregor Laimer, Angela Djanani, et al.. (2022). Multidisciplinary Treatment of Liver Metastases from Intracranial SFTs/HPCs: A Report of Three Consecutive Cases. Current Oncology. 29(11). 8720–8741. 2 indexed citations
9.
Riedl, Jakob M., Florian Posch, Lena Horvath, et al.. (2021). Gemcitabine/nab-Paclitaxel versus FOLFIRINOX for palliative first-line treatment of advanced pancreatic cancer: A propensity score analysis. European Journal of Cancer. 151. 3–13. 37 indexed citations
10.
Egger, Margot, Arno Beer, Markus Theurl, et al.. (2008). Monocyte migration: A novel effect and signaling pathways of catestatin. European Journal of Pharmacology. 598(1-3). 104–111. 75 indexed citations
11.
Djanani, Angela, Birgit Mosheimer, Nicole C. Kaneider, et al.. (2006). Heparan sulfate proteoglycan-dependent neutrophil chemotaxis toward PR-39 cathelicidin. Journal of Inflammation. 3(1). 14–14. 15 indexed citations
12.
Mosheimer, Birgit, Nicole C. Kaneider, Clemens Feistritzer, et al.. (2005). Syndecan-1 Is Involved in Osteoprotegerin-Induced Chemotaxis in Human Peripheral Blood Monocytes. The Journal of Clinical Endocrinology & Metabolism. 90(5). 2964–2971. 79 indexed citations
13.
Mosheimer, Birgit, Nicole C. Kaneider, Clemens Feistritzer, et al.. (2005). CD40-ligand-dependent induction of COX-2 gene expression in endothelial cells by activated platelets: inhibitory effects of atorvastatin. Blood Coagulation & Fibrinolysis. 16(2). 105–110. 24 indexed citations
14.
Feistritzer, Clemens, Johannes D. Clausen, Daniel H. Sturn, et al.. (2003). Natural killer cell functions mediated by the neuropeptide substance P. Regulatory Peptides. 116(1-3). 119–126. 67 indexed citations
15.
Feistritzer, Clemens, Daniel H. Sturn, Nicole C. Kaneider, Angela Djanani, & Christian J. Wiedermann. (2003). Endothelial protein C receptor-dependent inhibition of human eosinophil chemotaxis by protein C. Journal of Allergy and Clinical Immunology. 112(2). 375–381. 53 indexed citations
16.
Djanani, Angela, Nicole C. Kaneider, Daniel H. Sturn, & Christian J. Wiedermann. (2003). Agonist function of the neurokinin receptor antagonist, [d-Arg1,d-Phe5,d-Trp7,9,Leu11]substance P, in monocytes. Regulatory Peptides. 115(2). 123–129. 5 indexed citations
17.
Djanani, Angela, et al.. (2002). Modulation of Inflammation by Vasoactive Intestinal Peptide and Bombesin: Lack of Effects on Neutrophil Apoptosis. PubMed. 29(3). 93–96. 3 indexed citations
18.
Kaneider, Nicole C., Angela Djanani, Reiner Fischer‐Colbrie, & Christian J. Wiedermann. (2002). Sphingosine kinase-dependent directional migration of leukocytes in response to phorbol ester. Biochemical and Biophysical Research Communications. 297(4). 806–810. 18 indexed citations
19.
Kaneider, Nicole C., et al.. (2002). Antithrombin and Near‐Fatal Exertional Heat Stroke. PubMed. 29(3). 107–111. 11 indexed citations
20.
Kaneider, Nicole C., Christina M. Reinisch, Stefan Dunzendorfer, et al.. (2001). Induction of apoptosis and inhibition of migration of inflammatory and vascular wall cells by cerivastatin. Atherosclerosis. 158(1). 23–33. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel H. Sturn Breakdown of academic impact, for papers by Wilfried Schgoer Breakdown of academic impact, for papers by Anne Graham Breakdown of academic impact, for papers by Véronique Chobaz-Péclat Breakdown of academic impact, for papers by Sung Won Lee Breakdown of academic impact, for papers by Ichiro Fuse Breakdown of academic impact, for papers by David J. Elzi Breakdown of academic impact, for papers by Simon Allen Breakdown of academic impact, for papers by Yulia Bashenko
Rankless by CCL
2026